Eligibility Rejections are Appearing in Greater Frequency Across all Computer...
Four years after the Alice decision, we seem to just now be detecting the full impact of the decision. The initial response by the USPTO resulted in an somewhat expected increase in the percentage of...
View ArticleFederal Circuit: No matter how much the advance the claims recite, they are...
This case and the passage above merely confirms what we have long known to be true. The magnitude of the innovation does not matter. Whether there is an innovation does not matter. Certain advances,...
View ArticleMayo/Alice ‘Directed to’ Inquiry and a Split Federal Circuit: Vanda Pharma v....
n Vanda, Chief Judge Prost, one of the judges on the CellzDirect panel, dissented from the majority’s decision that found claims patent eligible for not being directed to a judicial exception in step...
View ArticleUSPTO asks Federal Circuit to Vacate, Remand 101 Case to Board in Light of...
Yesterday the United States Patent and Trademark Office (USPTO) filed a Director's Unopposed Motion to Vacate and Remand in In re Intelligent Medical Objects, Inc. After the decision of the Board the...
View ArticlePatent Office asks Federal Circuit to Allow Board to Reconsider Eligibility...
Yesterday I wrote about the United States Patent and Trademark Office filing a Director’s Unopposed Motion to Vacate and Remand in In re Intelligent Medical Objects, Inc., which was filed on June 5,...
View ArticleIancu: People have a right to know what is patent eligible
While the subject matter of the speech was similar, this speech by Director Iancu was different. It was much more direct and forceful than any of his previous speeches. Iancu asked how inventors are...
View ArticleRethinking Article III Standing in IPR Appeals at the Federal Circuit
In 2011, as part of the American Invents Act (“AIA”), Congress significantly restructured the way in which previously issued patents could be challenged. In some cases, existing post-issuance...
View ArticleFederal Circuit Hears Oral Arguments on St. Regis Appeal of Tribal Sovereign...
On Monday, June 4th, the Court of Appeals for the Federal Circuit heard oral arguments in St. Regis Mohawk Tribe v. Mylan Pharmaceuticals, a case appealed from the Patent Trial and Appeal Board (PTAB)...
View ArticleUSPTO issues guidance on patent eligibility of method of treatment claims in...
On June 7, 2018, the USPTO issued new guidance to its examining corps in the form of a memorandum discussing the Federal Circuit’s April 13, 2018 decision in Vanda Pharmaceuticals Inc. v. West-Ward...
View ArticlePatent Eligibility Determinations in Life Sciences Patent Cases
This article examines Supreme Court and Federal Circuit analyses of patent eligibility under 35 U.S.C. § 101 where the patent claims at issue were directed to Life Sciences-related technologies. I...
View ArticleBlockchain Patenting Strategies in view of the Berkheimer Decision
The same factual analysis required in Berkheimer under step 2B should apply to fundamental economic practice analysis of claims under step 2A. The questions have similar factual underpinnings in both...
View ArticleFederal Circuit invites SAP America to Respond to InvestPic Petition for...
InvestPic filed a combined petition for panel rehearing and rehearing en banc on June 19, 2018, making two arguments. First, that the original decision must be vacated and remanded because the claims...
View Article6 Years Later: The Effects of the Mayo Decision on Diagnostic Methods
2018 celebrates the six-year anniversary of one of the most important Supreme Court decisions of the modern era. On March 20, 2012, the Court handed down its ruling in Mayo v. Prometheus Laboratories....
View ArticleSoftware Patent-Eligible Subject Matter: Claiming Improvements in Computer...
Particularize the claims. This helps overcome the “abstract” part of a 101 rejection. Put details into the claims to define the steps performed in the software and hardware to a granular degree....
View ArticleThe Implicit Exception to § 101 for Abstract Ideas Should Be Narrowly Construed
There is an alternative route is available to stay true to Supreme Court eligibility jurisprudence: Apply the Supreme Court’s standard approach of narrowly construing statutory exceptions to narrowly...
View ArticleIn an Abstract Idea Context, Little Is Unmistakably Within the Bright-line...
It seems clear that the Supreme Court did not intend to categorically prohibit patenting of everything which can be characterized as an abstract idea at some level because the Court indicated that...
View ArticleNarrowly Construing the Bright-line Eligibility Prohibition Does Not Prevent...
Narrowly construing the § 101 eligibility exception for abstract ideas is not only suggested by Supreme Court guidance, but also could potentially allow for increased coherence and consistency while...
View ArticleWhere is the line between patentable subject matter and non-patentable...
A conflict exists between the incentive to invent and the breadth of patent-eligible subject matter. It has become difficult to recognize the line between patentable subject matter and non-patentable...
View ArticleDissecting Dissents for Ex Parte Appeals
Dissent is not the highest form of judgment for judges on the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO). As discussed in further detail below, our...
View ArticleCan I hold on long enough until the madness stops?
If someone told me when starting my career in 1976 that I would discover a process that has been beyond the reach of professionals and experts for over 62 years, I would have laughed. If the same...
View Article